Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.10
+3.27%
Mkt Cap $653.51M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$3.70
Range $3.70 – $3.70
Implied Upside
-9.8%
Consensus $3.70 vs current $4.10